BP1001 plus decitabine

Drug identity checked against registry records

Also recorded as L-Grb-2; Liposomal Grb-2

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLNCT02781883Bio-Path Holdings, Inc.Phase 2Recruiting2027-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.